Challenges Associated With Next-Generation Sequencing of Breast Cancer

To the Editor I appreciated the nice review of the current status and promise for the use of next-generation sequencing (NGS) in identifying actionable somatic and germline molecular abnormalities as breast cancer therapeutic targets. The authors^(p262) conclude that "circulating tumor DNA analysis, once sensitive and broad enough" will enable the identification of these actionable abnormalities.

http://ift.tt/2qW9wdv